CFTR and cancer: Assays can be broadly partitioned into those which detect either non-cancer-related variants (eg, CFTR p.F508del is universally accepted as pathogenic, but solely as a mutation that results in cystic fibrosis and has no known association with oncology) or cancer-related variants.